Investigating how tRNA fragments affect SARS-CoV-2 infection in the nose
tRNA-derived RNA Fragments and their Role in Nasal SARS-CoV-2 Infection
This study is looking at tiny pieces of RNA in your body to see how they help fight against COVID-19, with the hope of finding new ways to treat the virus and improve care for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10867808 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of tRNA-derived RNA fragments (tRFs) in the body's response to SARS-CoV-2, the virus responsible for COVID-19. By analyzing nasal swab samples, researchers aim to identify how these small non-coding RNAs are regulated during infection and how they might influence the virus's ability to replicate. The study seeks to uncover potential therapeutic targets that could lead to new antiviral treatments against COVID-19. Patients may benefit from insights gained into how their bodies respond to the virus, potentially leading to improved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have tested positive for SARS-CoV-2 or are at high risk of infection.
Not a fit: Patients who are not infected with SARS-CoV-2 or those who have recovered from the virus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antiviral therapies that enhance the body's ability to combat SARS-CoV-2.
How similar studies have performed: Other research has shown promise in targeting non-coding RNAs for antiviral therapies, suggesting that this approach could be effective.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Bao, Xiaoyong — University of Texas Med Br Galveston
- Study coordinator: Bao, Xiaoyong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.